Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer
- PMID: 24777110
- PMCID: PMC4677264
- DOI: 10.1093/jnci/dju093
Tracking and evaluating molecular tumor markers with cancer registry data: HER2 and breast cancer
Figures

Comment on
-
US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.J Natl Cancer Inst. 2014 Apr 28;106(5):dju055. doi: 10.1093/jnci/dju055. J Natl Cancer Inst. 2014. PMID: 24777111 Free PMC article.
References
-
- Clemmesen J. Carcinoma of the breast. Br J Radiol. 1948;21(252):583–590. - PubMed
-
- Lilienfeld AM, Johnson EA. The age distribution in female breast and genital cancers. Cancer. 1955;8(5):875–882. - PubMed
-
- Moolgavkar SH, Lee JA, Hade RD. Comparison of age-specific mortality from breast cancer in males in the United States and Japan. J Natl Cancer Inst. 1978;60(6):1223–1225. - PubMed
-
- Anderson WF, Matsuno RK. Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst. 2006;98(14):948–951. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous